Page 23 - Clinical variability in Noonan syndrome with emphasison ear and eye
P. 23

                48. Lee DA, Portnoy S, Hill P, Gillberg C, Patton MA. Psychological profile of children with Noonan syndrome. Developmental Medicine and Child Neurology. 2005;47:35-8.
49. Pierpont EI, Pierpont ME, Mendelsohn NJ, Roberts AE, Tworog-Dube E, Seidenberg MS. Genotype differences in cognitive functioning in Noonan syndrome. Genes, Brain, and Behavior. 2009;8:275-282.
50. Vegunta S, Cotugno R, Williamson A, Grebe TA. Chronic pain in Noonan Syndrome: A previously unreported but common symptom. American Journal of Medical Genetics Part A. 2015;167:2998-3005.
51. Addissie YA, Kotecha U, Hart RA, Martinez AF, Kruszka P, Muenke M. Craniosynostosis and Noonan syndrome with KRAS mutations: Expanding the phenotype with a case report and review of the literature. American Journal of Medical Genetics Part A. 2015;167A:2657- 2663.
52. Marcus KA, Sweep CG, van der Burgt I, Noordam C. Impaired Sertoli cell function in males diagnosed with Noonan syndrome. Journal of pediatric endocrinology & metabolism. 2008;21:1079 -1084.
53. Allanson JE. Noonan syndrome. American Journal of Medical Genetics Part C, Seminars in Medical Genetics. 2007;145C:274-279.
54. Miller M, Motulsky AC. Noonan syndrome in an adult family presenting with chronic lymphedema. The American Journal of Medicine. 1978;65:379-383.
55. Witt DR, McGillivray BC, Allanson JE, Hughes HE, Hathaway WE, Zipursky A, Hall JG. Bleeding diathesis in Noonan syndrome: a common association. American Journal of Medical Genetics. 1988;31:305-317.
56. Briggs BJ, Dickerman JD. Bleeding disorders in Noonan syndrome. Pediatric Blood & Cancer. 2012;58:167-172.
57. Jongmans MC, van der Burgt I, Hoogerbrugge PM, Noordam K, Yntema HG, Nillesen WM, et al. Cancer risk in patients with Noonan syndrome carrying a PTPN11 mutation. European Journal of Human Genetics. 2011;19:870-874.
58. Kratz CP, Franke L, Peters H, Kohlschmidt N, Kazmierczak B, Finckh U, et al. Cancer spectrum and frequency among children with Noonan, Costello, and cardio-facio-cutaneous syndromes. British Journal of Cancer. 2015;112:1392-1397.
59. Lee NB, Kelly L, Sharland M. Ocular manifestations of Noonan syndrome. Eye. 1992;6:328- 334.
60. Alfieri P, Cesarini L, Zampino G, Pantaleoni F, Selicorni A, Salerni A et al. Visual function in Noonan and LEOPARD syndrome. 2008;39:335-340.
61. Reynolds DJ, Rubin SE, Fox J, Kodsi SR. Ocular manifestations in Noonan syndrome in the pediatric patient. Journal of American Association of Pediatric Ophthalmology and Strabismus. 2004;8:282-283.
62. Horiguchi T, Takeshita K. Neuropsychological developmental change in a case with Noonan syndrome: longitudinal assessment. Brain & Development. 2003;25:291-293.
63. Cremers C. Letter: Hearing loss in Noonan syndrome. Journal of Pediatrics. 1976;88:363.
64. Qiu WW, Yin SS, Stucker FJ. Audiologic manifestations of Noonan syndrome. Otolaryngology
Head and Neck Surgery. 1998;118:319-323.
65. Naficy S, Shepard NT, Telian SA. Multiple temporal bone anomalies associated with Noonan
syndrome. Otolaryngology Head and Neck Surgery. 1997;116:265-267.
66. Shah N, Rodriguez M, Louis DS, Lindley K, Milla PJ. Feeding difficulties and foregut dysmotility
in Noonan’s syndrome. Archives of disease in childhood. 1999;81:28-31.
67. Rauen KA. The RASopathies. Annual Review of Genomics and Human Genetics. 2013;14:355-
369.
68. Aoki Y, Niihori T, Inoue S, Matsubara Y. Recent advances in RASopathies. Journal of Human
Genetics. 2016;61:33-39.
69. Tartaglia M, Mehler EL, Goldberg R, Zampino G, Brunner HG, Kremer H, et al. Mutations
in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nature Genetics. 2001;29:465-468.
INTRODUCTION
 21
1




































































   21   22   23   24   25